...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: https://scr.zacks.co...
7
May 04, 2020 10:59AM
5
May 04, 2020 11:02AM
5
May 04, 2020 11:39AM
4
May 05, 2020 07:32PM
8
May 06, 2020 08:51AM

Excellent piece, narmac.

Worth repeating on the RVX HUB, don't you think as it is very much applicable there as well?

 

Koo

4
May 06, 2020 03:21PM
Share
New Message
Please login to post a reply